Marinus Pharmaceuticals Cash Flow Statement

Financials in millions PKR. Fiscal year is October - September.

Millions PKR. Fiscal year is Oct - Sep.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021	Sep '20 Sep 30, 2020
Net Income	152.22	-799.08	1,443	289.13	-15.11	46.74
Depreciation & Amortization	217.25	218.45	191.65	188.35	206.07	177.82
Loss (Gain) From Sale of Assets	-11.75	-10.62	-94.35	-3.13	-10.14	-26.39
Loss (Gain) From Sale of Investments	-614.94	-669.46	-84.52	199.27	20.03	-131.47
Loss (Gain) on Equity Investments	178.25	652.28	-911.79	-440.14	-61.6	-76.92
Provision & Write-off of Bad Debts	-	-	-	-	-	26.54
Other Operating Activities	-376.79	143.6	731.26	-61.15	106.07	-694.76
Change in Accounts Receivable	385.14	-190.81	-188.18	-30.75	-51.46	60.93
Change in Inventory	3,397	-2,038	965.13	-1,026	-508.09	990.52
Change in Accounts Payable	591.8	-48.83	100.31	-14.36	17.15	-216.49
Change in Unearned Revenue	-169.08	-357.48	-97.26	471.35	-1.9	-379.1
Change in Other Net Operating Assets	-390.82	71.49	-142.91	116.96	-42.48	662.81
Operating Cash Flow	3,358	-3,029	1,912	-310.81	-341.47	440.24
Operating Cash Flow Growth	-	-	-	-	-	-61.68%
Capital Expenditures	-72.72	-127.58	-121.99	-242.52	-339.36	-234.64
Sale of Property, Plant & Equipment	13.43	11.33	142.15	3.93	14.01	35.13
Investment in Securities	64.38	956.22	-83.79	343.7	-334.65	200.88
Other Investing Activities	-	25	275	325	212.5	275
Investing Cash Flow	5.09	864.97	211.37	430.11	-447.51	276.37
Long-Term Debt Issued	-	-	-	-	115.15	192.57
Total Debt Issued	-5,121	-	-	-	115.15	192.57
Long-Term Debt Repaid	-	-164.14	-542.97	-251.03	-18.75	-21.56
Total Debt Repaid	-787.24	-164.14	-542.97	-251.03	-18.75	-21.56
Net Debt Issued (Repaid)	-5,909	-164.14	-542.97	-251.03	96.4	171.02
Common Dividends Paid	-70.89	-296.27	-323.29	-39.99	-72.71	-97.81
Financing Cash Flow	-5,979	-460.42	-866.25	-291.02	23.69	73.21
Net Cash Flow	-2,616	-2,624	1,257	-171.72	-765.28	789.81
Free Cash Flow	3,285	-3,156	1,790	-553.32	-680.83	205.6
Free Cash Flow Growth	-	-	-	-	-	-78.73%
Free Cash Flow Margin	23.55%	-28.72%	16.30%	-8.02%	-11.23%	3.20%
Free Cash Flow Per Share	43.87	-42.13	23.89	-7.38	-9.18	2.74
Cash Interest Paid	1,036	985.76	676.5	452.54	217.73	443.02
Cash Income Tax Paid	438.99	205.15	203.29	140.82	146.86	152.2
Levered Free Cash Flow	3,584	-2,705	1,469	-425.17	-700.21	642.96
Unlevered Free Cash Flow	3,974	-1,925	1,859	-97.86	-536.38	854.97
Change in Working Capital	3,814	-2,564	637.1	-483.15	-586.78	1,119

Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q